GH1 and metabolic dysfunction-associated steatohepatitis: Low GH action in obesity might also lead to metabolic alterations of other tissues such as the adipose tissue and skeletal muscle that might also contribute to deteriorated insulin sensitivity and glucose tolerance in obese patients with NASH.